LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 165

Search options

  1. Article ; Online: A protocol to analyze single-cell RNA-seq data from Mycobacterium tuberculosis-infected mice lung.

    Akter, Sadia / Khader, Shabaana A

    STAR protocols

    2023  Volume 4, Issue 3, Page(s) 102544

    Abstract: Processing and analyzing single-cell RNA-seq (scRNA-seq) from lung cells are challenging due to the complexity of cell subtypes and biological variations within sample groups. Here, we present a protocol for performing an in-depth assessment on lung ... ...

    Abstract Processing and analyzing single-cell RNA-seq (scRNA-seq) from lung cells are challenging due to the complexity of cell subtypes and biological variations within sample groups. Here, we present a protocol for performing an in-depth assessment on lung lymphocyte populations derived from healthy and Mycobacterium tuberculosis-infected mice. We describe steps for downloading processed scRNA-seq data, integrating samples across different conditions, and performing cluster analysis. We then detail procedures for identifying lymphoid cell subtypes, differential analysis, and pathway enrichment analysis. For complete details on the use and execution of this protocol, please refer to Akter et al. (2022).
    MeSH term(s) Animals ; Mice ; Mycobacterium tuberculosis/genetics ; Single-Cell Gene Expression Analysis ; Cluster Analysis
    Language English
    Publishing date 2023-08-31
    Publishing country United States
    Document type Journal Article
    ISSN 2666-1667
    ISSN (online) 2666-1667
    DOI 10.1016/j.xpro.2023.102544
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.

    Bobba, Suhas / Khader, Shabaana A

    Trends in immunology

    2023  Volume 44, Issue 9, Page(s) 712–723

    Abstract: Tuberculosis (TB) is the leading cause of death due to an infectious agent, with more than 1.5 million deaths attributed to TB annually worldwide. The global dissemination of drug resistance across Mycobacterium tuberculosis (Mtb) strains, causative of ... ...

    Abstract Tuberculosis (TB) is the leading cause of death due to an infectious agent, with more than 1.5 million deaths attributed to TB annually worldwide. The global dissemination of drug resistance across Mycobacterium tuberculosis (Mtb) strains, causative of TB, resulted in an estimated 450 000 cases of drug-resistant (DR) TB in 2021. Dysregulated immune responses have been observed in patients with multidrug resistant (MDR) TB, but the effects of drug resistance acquisition and impact on host immunity remain obscure. In this review, we compile studies that span aspects of altered host-pathogen interactions and highlight research that explores how drug resistance and immunity might intersect. Understanding the immune processes differentially induced during DR TB would aid the development of rational therapeutics and vaccines for patients with MDR TB.
    MeSH term(s) Humans ; Rifampin ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Tuberculosis/drug therapy ; Mycobacterium tuberculosis ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/microbiology
    Chemical Substances Rifampin (VJT6J7R4TR) ; Antitubercular Agents
    Language English
    Publishing date 2023-08-03
    Publishing country England
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 2036831-8
    ISSN 1471-4981 ; 1471-4906
    ISSN (online) 1471-4981
    ISSN 1471-4906
    DOI 10.1016/j.it.2023.07.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Inflammatory comorbidities: to train or not to train?

    Bobba, Suhas / Khader, Shabaana A

    Trends in immunology

    2022  Volume 43, Issue 6, Page(s) 420–422

    Abstract: Inflammatory stimuli reprogram innate immune cells to generate rigorous responses to future challenge with heterologous stimuli through trained immunity. Li et al. show that training of hematopoietic stem cells (HSCs) in the bone marrow primes cells to ... ...

    Abstract Inflammatory stimuli reprogram innate immune cells to generate rigorous responses to future challenge with heterologous stimuli through trained immunity. Li et al. show that training of hematopoietic stem cells (HSCs) in the bone marrow primes cells to generate more inflammatory myeloid progeny and, thereby, mechanistically links inflammatory comorbidities.
    MeSH term(s) Bone Marrow ; Hematopoietic Stem Cells ; Humans ; Immunity, Innate
    Language English
    Publishing date 2022-05-08
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2036831-8
    ISSN 1471-4981 ; 1471-4906
    ISSN (online) 1471-4981
    ISSN 1471-4906
    DOI 10.1016/j.it.2022.04.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Saponin TQL1055 adjuvant-containing vaccine confers protection upon

    Ahmed, Mushtaq / Farris, Eric / Swanson, Rosemary V / Das, Shibali / Yang, Yan / Martin, Tyler / Khader, Shabaana A

    Human vaccines & immunotherapeutics

    2024  Volume 20, Issue 1, Page(s) 2302070

    Abstract: Tuberculosis (TB), caused by the intracellular ... ...

    Abstract Tuberculosis (TB), caused by the intracellular pathogen
    MeSH term(s) Adult ; Child ; Infant ; Humans ; Animals ; Mice ; Child, Preschool ; Mycobacterium tuberculosis ; BCG Vaccine ; Adjuvants, Immunologic ; Tuberculosis Vaccines ; Tuberculosis, Pulmonary/prevention & control ; Mycobacterium bovis ; Saponins
    Chemical Substances BCG Vaccine ; Adjuvants, Immunologic ; Tuberculosis Vaccines ; Saponins
    Language English
    Publishing date 2024-01-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2664176-8
    ISSN 2164-554X ; 2164-5515
    ISSN (online) 2164-554X
    ISSN 2164-5515
    DOI 10.1080/21645515.2024.2302070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Elevated Level of Circulating but Not Urine S100A8/A9 Identifies Poor COVID-19 Outcomes.

    Mellett, Leah / Amarasinghe, Gaya / Farnsworth, Christopher W / Khader, Shabaana A

    ACS infectious diseases

    2023  Volume 9, Issue 10, Page(s) 1815–1820

    Abstract: The alarmin calprotectin (S100A8/A9) is thought to drive a cytokine storm, a hallmark of severe COVID-19. Recent studies report circulating S100A8/A9 levels can distinguish COVID-19 severity but have only been conducted in non-U.S. cohorts and mainly ... ...

    Abstract The alarmin calprotectin (S100A8/A9) is thought to drive a cytokine storm, a hallmark of severe COVID-19. Recent studies report circulating S100A8/A9 levels can distinguish COVID-19 severity but have only been conducted in non-U.S. cohorts and mainly focus on serum S100A8/A9 levels. Thus, we quantified S100A8/A9 in serum and urine samples from a hospital cohort in St. Louis, Missouri, to expand the understanding of S100A8/A9 as a prognostic biomarker for COVID-19. Elevated S100A8/A9 serum levels were observed in ICU patients (
    MeSH term(s) Humans ; Calgranulin B ; COVID-19/diagnosis ; Calgranulin A ; Leukocyte L1 Antigen Complex ; Biomarkers
    Chemical Substances Calgranulin B ; Calgranulin A ; Leukocyte L1 Antigen Complex ; Biomarkers
    Language English
    Publishing date 2023-10-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2373-8227
    ISSN (online) 2373-8227
    DOI 10.1021/acsinfecdis.3c00249
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes.

    Mellett, Leah / Khader, Shabaana A

    Cytokine & growth factor reviews

    2021  Volume 63, Page(s) 90–97

    Abstract: Coronavirus disease 2019 (COVID-19) has a broad range of clinical manifestations, highlighting the need for specific diagnostic tools to predict disease severity and improve patient prognosis. Recently, calprotectin (S100A8/A9) has been proposed as a ... ...

    Abstract Coronavirus disease 2019 (COVID-19) has a broad range of clinical manifestations, highlighting the need for specific diagnostic tools to predict disease severity and improve patient prognosis. Recently, calprotectin (S100A8/A9) has been proposed as a potential biomarker for COVID-19, as elevated serum S100A8/A9 levels are associated with critical COVID-19 cases and can distinguish between mild and severe disease states. S100A8/A9 is an alarmin that mediates host proinflammatory responses during infection and it has been postulated that S100A8/A9 modulates the cytokine storm; the hallmark of fatal COVID-19 cases. However, it has yet to be determined if S100A8/A9 is a bona-fide biomarker for COVID-19. S100A8/A9 is widely implicated in a variety of inflammatory conditions, such as cystic fibrosis (CF) and chronic obstructive pulmonary disorder (COPD), as well as pulmonary infectious diseases, including tuberculosis and influenza. Therefore, understanding how S100A8/A9 levels correlate with immune responses during inflammatory diseases is necessary to evaluate its candidacy as a potential COVID-19 biomarker. This review will outline the protective and detrimental roles of S100A8/A9 during infection, summarize the recent findings detailing the contributions of S100A8/A9 to COVID-19 pathogenesis, and highlight its potential as diagnostic biomarker and a therapeutic target for pulmonary infectious diseases, including COVID-19.
    MeSH term(s) Biomarkers ; COVID-19 ; Calgranulin A ; Calgranulin B ; Humans ; SARS-CoV-2
    Chemical Substances Biomarkers ; Calgranulin A ; Calgranulin B ; S100A8 protein, human ; S100A9 protein, human
    Language English
    Publishing date 2021-10-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1330534-7
    ISSN 1879-0305 ; 1359-6101
    ISSN (online) 1879-0305
    ISSN 1359-6101
    DOI 10.1016/j.cytogfr.2021.10.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Lung type 3 innate lymphoid cells respond early following

    Das, Shibali / Chauhan, Kuldeep Singh / Ahmed, Mushtaq / Akter, Sadia / Lu, Lan / Colonna, Marco / Khader, Shabaana A

    mBio

    2024  Volume 15, Issue 4, Page(s) e0329923

    Abstract: Tuberculosis is the leading cause of death due to an infectious disease worldwide. Innate lymphoid type 3 cells (ILC3s) mediate early protection during : Importance: Tuberculosis is a leading cause of death due to a single infectious agent accounting ... ...

    Abstract Tuberculosis is the leading cause of death due to an infectious disease worldwide. Innate lymphoid type 3 cells (ILC3s) mediate early protection during
    Importance: Tuberculosis is a leading cause of death due to a single infectious agent accounting for 1.6 million deaths each year. In our study, we determined the role of type 3 innate lymphoid cells in early immune events necessary for achieving protection during
    MeSH term(s) Mice ; Animals ; Immunity, Innate ; Lymphocytes ; Tuberculosis ; Lung ; Mycobacterium tuberculosis ; Vaccines
    Chemical Substances Vaccines
    Language English
    Publishing date 2024-02-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mbio.03299-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The Tale of IL-12 and IL-23: A Paradigm Shift.

    Khader, Shabaana A / Thirunavukkarasu, Shyamala

    Journal of immunology (Baltimore, Md. : 1950)

    2019  Volume 202, Issue 3, Page(s) 629–630

    MeSH term(s) Animals ; Autoimmune Diseases/immunology ; Humans ; Inflammation/immunology ; Interleukin-12/immunology ; Interleukin-23/immunology ; Mice
    Chemical Substances Interleukin-23 ; Interleukin-12 (187348-17-0)
    Language English
    Publishing date 2019-01-22
    Publishing country United States
    Document type Classical Article ; Journal Article
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.1801603
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immunometabolism during Mycobacterium tuberculosis Infection.

    Howard, Nicole C / Khader, Shabaana A

    Trends in microbiology

    2020  Volume 28, Issue 10, Page(s) 832–850

    Abstract: Over a quarter of the world's population is infected with Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). Approximately 3.4% of new and 18% of recurrent cases of TB are multidrug-resistant (MDR) or rifampicin-resistant. Recent ...

    Abstract Over a quarter of the world's population is infected with Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). Approximately 3.4% of new and 18% of recurrent cases of TB are multidrug-resistant (MDR) or rifampicin-resistant. Recent evidence has shown that certain drug-resistant strains of Mtb modulate host metabolic reprogramming, and therefore immune responses, during infection. However, it remains unclear how widespread these mechanisms are among circulating MDR Mtb strains and what impact drug-resistance-conferring mutations have on immunometabolism during TB. While few studies have directly addressed metabolic reprogramming in the context of drug-resistant Mtb infection, previous literature examining how drug-resistance mutations alter Mtb physiology and differences in the immune response to drug-resistant Mtb provides significant insights into how drug-resistant strains of Mtb differentially impact immunometabolism.
    MeSH term(s) Animals ; Antitubercular Agents/pharmacology ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Humans ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/metabolism ; Rifampin/pharmacology ; Tuberculosis/immunology ; Tuberculosis/microbiology
    Chemical Substances Antitubercular Agents ; Bacterial Proteins ; Rifampin (VJT6J7R4TR)
    Language English
    Publishing date 2020-05-11
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1158963-2
    ISSN 1878-4380 ; 0966-842X
    ISSN (online) 1878-4380
    ISSN 0966-842X
    DOI 10.1016/j.tim.2020.04.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y.

    Bobba, Suhas / Chauhan, Kuldeep S / Akter, Sadia / Das, Shibali / Mittal, Ekansh / Mathema, Barun / Philips, Jennifer A / Khader, Shabaana A

    PLoS pathogens

    2024  Volume 20, Issue 4, Page(s) e1012137

    Abstract: Interleukin-1 (IL-1) signaling is essential for controlling virulent Mycobacterium tuberculosis (Mtb) infection since antagonism of this pathway leads to exacerbated pathology and increased susceptibility. In contrast, the triggering of type I interferon ...

    Abstract Interleukin-1 (IL-1) signaling is essential for controlling virulent Mycobacterium tuberculosis (Mtb) infection since antagonism of this pathway leads to exacerbated pathology and increased susceptibility. In contrast, the triggering of type I interferon (IFN) signaling is associated with the progression of tuberculosis (TB) disease and linked with negative regulation of IL-1 signaling. However, mice lacking IL-1 signaling can control Mtb infection if infected with an Mtb strain carrying the rifampin-resistance conferring mutation H445Y in its RNA polymerase β subunit (rpoB-H445Y Mtb). The mechanisms that govern protection in the absence of IL-1 signaling during rpoB-H445Y Mtb infection are unknown. In this study, we show that in the absence of IL-1 signaling, type I IFN signaling controls rpoB-H445Y Mtb replication, lung pathology, and excessive myeloid cell infiltration. Additionally, type I IFN is produced predominantly by monocytes and recruited macrophages and acts on LysM-expressing cells to drive protection through nitric oxide (NO) production to restrict intracellular rpoB-H445Y Mtb. These findings reveal an unexpected protective role for type I IFN signaling in compensating for deficiencies in IL-1 pathways during rpoB-H445Y Mtb infection.
    MeSH term(s) Mycobacterium tuberculosis ; Interferon Type I/metabolism ; Animals ; Mice ; Rifampin/pharmacology ; Signal Transduction ; DNA-Directed RNA Polymerases/metabolism ; DNA-Directed RNA Polymerases/genetics ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Mutation ; Mice, Inbred C57BL ; Drug Resistance, Bacterial/genetics ; Tuberculosis/microbiology ; Tuberculosis/immunology ; Tuberculosis/genetics ; Mice, Knockout
    Chemical Substances Interferon Type I ; Rifampin (VJT6J7R4TR) ; DNA-Directed RNA Polymerases (EC 2.7.7.6) ; Bacterial Proteins ; rpoB protein, Mycobacterium tuberculosis
    Language English
    Publishing date 2024-04-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7374
    ISSN (online) 1553-7374
    ISSN 1553-7374
    DOI 10.1371/journal.ppat.1012137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top